The TGFβ-TGFβR and EGFR-NRG1 binding between receptor and ligand was obvious in CAF/CT26 subgroups, revealing that the CAFs and CT26 tumor cells cross talk through TGF pathway and affect the expression of EGFR to transform the tumor cells. Here, NRG1 is linked to neoplasm.